Deutsche Bank’s Blueprint Medicines BPMC Stock Holding History

Deutsche Bank’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-189,250	Closed	-$24.3M	–	3615
2025 Q2	$24.3M	Sell	189,250 -10,687	-5%	-$1.11M	0.01%	783
2025 Q1	$17.7M	Sell	199,937 -61,426	-24%	-$5.99M	0.01%	851
2024 Q4	$22.8M	Buy	261,363 +22,412	+9%	+$2.05M	0.01%	812
2024 Q3	$22.1M	Buy	238,951 +18,920	+9%	+$1.88M	0.01%	809
2024 Q2	$23.7M	Buy	220,031 +93,564	+74%	+$9.37M	0.01%	767
2024 Q1	$12M	Sell	126,467 -16,368	-11%	-$1.4M	0.01%	967
2023 Q4	$13.2M	Buy	142,835 +60,268	+73%	+$3.9M	0.01%	911
2023 Q3	$4.15M	Buy	82,567 +3,805	+5%	+$203K	﹤0.01%	1094
2023 Q2	$4.98M	Sell	78,762 -28,246	-26%	-$1.54M	﹤0.01%	1236
2023 Q1	$4.81M	Buy	107,008 +21,791	+26%	+$982K	﹤0.01%	1254
2022 Q4	$3.73M	Sell	85,217 -100,195	-54%	-$4.8M	﹤0.01%	1343
2022 Q3	$12.2M	Sell	185,412 -9,229	-5%	-$593K	0.01%	895
2022 Q2	$9.83M	Sell	194,641 -3,426	-2%	-$201K	0.01%	1000
2022 Q1	$12.7M	Sell	198,067 -3,418	-2%	-$245K	0.01%	996
2021 Q4	$21.6M	Sell	201,485 -226,543	-53%	-$23.7M	0.01%	836
2021 Q3	$44M	Sell	428,028 -3,860	-0.9%	-$359K	0.02%	655
2021 Q2	$38M	Buy	431,888 +61,832	+17%	+$5.67M	0.02%	686
2021 Q1	$36M	Sell	370,056 -53,295	-13%	-$5.32M	0.02%	694
2020 Q4	$47.5M	Sell	423,351 -2,589	-0.6%	-$273K	0.03%	521
2020 Q3	$39.5M	Sell	425,940 -57,397	-12%	-$4.42M	0.03%	517
2020 Q2	$37.7M	Buy	483,337 +132,374	+38%	+$8.95M	0.03%	516
2020 Q1	$20.5M	Buy	350,963 +55,537	+19%	+$3.57M	0.02%	641
2019 Q4	$23.7M	Sell	295,426 -6,702	-2%	-$502K	0.02%	724
2019 Q3	$22.2M	Sell	302,128 -8,782	-3%	-$759K	0.02%	741
2019 Q2	$29.3M	Buy	310,910 +148,811	+92%	+$12.3M	0.02%	788
2019 Q1	$13M	Buy	162,099 +13,142	+9%	+$971K	0.01%	1234
2018 Q4	$8.03M	Sell	148,957 -64,010	-30%	-$3.89M	0.01%	1445
2018 Q3	$16.6M	Sell	212,967 -196,305	-48%	-$13.6M	0.01%	1252
2018 Q2	$26M	Buy	409,272 +255,150	+166%	+$20.3M	0.01%	1018
2018 Q1	$14.1M	Buy	154,122 +40,840	+36%	+$3.52M	0.01%	1350
2017 Q4	$8.54M	Buy	113,282 +57,102	+102%	+$4.02M	0.01%	1615
2017 Q3	$3.91M	Sell	56,180 -25,809	-31%	-$1.38M	﹤0.01%	2067
2017 Q2	$4.15M	Buy	81,989 +44,191	+117%	+$1.88M	﹤0.01%	2055
2017 Q1	$1.51M	Buy	37,798 +11,395	+43%	+$408K	﹤0.01%	2408
2016 Q4	$737K	Sell	26,403 -9,828	-27%	-$296K	﹤0.01%	2899
2016 Q3	$1.07M	Sell	36,231 -30,485	-46%	-$757K	﹤0.01%	2780
2016 Q2	$1.35M	Buy	66,716 +1,551	+2%	+$28.2K	﹤0.01%	2675
2016 Q1	$1.17M	Sell	65,165 -53,082	-45%	-$921K	﹤0.01%	2717
2015 Q4	$3.11M	Sell	118,247 -65,724	-36%	-$1.48M	﹤0.01%	2123
2015 Q3	$3.92M	Buy	183,971 +178,560	+3,300%	+$4.94M	﹤0.01%	1980
2015 Q2	$142K	Buy	+5,411	New	+$155K	﹤0.01%	4059

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's BPMC Position: Q3 2025 in Review

Deutsche Bank sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 189,250 shares — an estimated $24.3M sold.

Deutsche Bank first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $47.5M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Deutsche Bank reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Deutsche Bank sold 189,250 Blueprint Medicines shares in Q3 2025, an estimated $24.3M.
Deutsche Bank first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
Deutsche Bank's Blueprint Medicines position peaked at $47.5M in Q4 2020.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.